Hostname: page-component-77f85d65b8-g4pgd Total loading time: 0 Render date: 2026-04-19T22:27:45.442Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost

Published online by Cambridge University Press:  02 January 2015

Nicholas Graves ,
Diana Weinhold ,
Edward Tong ,
Frances Birrell ,
Shane Doidge ,
Prabha Ramritu ,
Kate Halton ,
David Lairson  and
Michael Whitby
Nicholas Graves*
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia Institute of Biomedical and Health Innovation, School of Public Health, Queensland University of Technology, Brisbane, Australia
Diana Weinhold
Affiliation:
London School of Economics, London, United Kingdom
Edward Tong
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia
Frances Birrell
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia
Shane Doidge
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia
Prabha Ramritu
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia
Kate Halton
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia Institute of Biomedical and Health Innovation, School of Public Health, Queensland University of Technology, Brisbane, Australia
David Lairson
Affiliation:
School of Public Health, University of Texas Health Science Center at Houston, Houston
Michael Whitby
Affiliation:
Centre for Healthcare Related Infection Surveillance and Prevention, Princess Alexandra Hospital, Brisbane, Australia
*
School of Public Health, Queensland University of Technology, Victoria Park Rd., Kelvin Grove, QLD 4059, Australia (n.graves@qut.edu.au)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To estimate the independent effect of a single lower respiratory tract infection, urinary tract infection, or other healthcare-acquired infection on length-of-stay and variable costs and to demonstrate the bias from omitted variables that is present in previous estimates.

Design.

Prospective cohort study.

Setting.

A tertiary care referral hospital and regional district hospital in southeast Queensland, Australia.

Patients.

Adults aged 18 years or older with a minimum inpatient stay of 1 night who were admitted to selected clinical specialities.

Results.

Urinary tract infection was not associated with an increase in length of hospital stay or variable costs. Lower respiratory tract infection was associated with an increase of 2.58 days in the hospital and variable costs of AU$24, whereas other types of infection were associated with an increased length of stay of 2.61 days but not with variable costs. Many other factors were found to be associated with increased length of stay and variable costs alongside healthcare-acquired infection. The exclusion of these variables caused a positive bias in the estimates of the costs of healthcare-acquired infection.

Conclusions.

The existing literature may overstate the costs of healthcare-acquired infection because of bias, and the existing estimates of excess costs may not make intuitive sense to clinicians and policy makers. Accurate estimates of the costs of healthcare-acquired infection should be made and used in appropriately designed decision-analytic economic models (ie, cost-effectiveness models) that will make valid and believable predictions of the economic value of increased infection control.

Information

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 3 , March 2007 , pp. 280 - 292
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Haley, RW. Cost-benefit analysis of infection control activities. In: Brachman, P, Bennett, J, eds. Hospital Infections. Philadelphia, PA: Lippincott-Raven; 1998:249–267.Google Scholar
2.Scheckler, WE. Hospital costs of nosocomial infections: a prospective three month study in a community hospital. Infect Control 1980;1:150–152.Google Scholar
3.Plowman, RP, Graves, N, Griffin, MAS, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198–209.Google Scholar
4.Delgado-Rodriguez, M, Bueno-Cavanillas, A, Lopez-Gigosos, R, et al. Hospital stay length as an effect modifier of other risk factors for nosocomial infection. Eur J Epidemiol 1990;6:34–39.Google Scholar
5.Glynn, A, Ward, V, Wilson, Iet al. Hospital Acquired Infection: Surveillance Policies and Practice. London: Public Health Laboratory Service; 1997.Google Scholar
6.Harbarth, S, Sax, H, Gastmeier, P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003;54:258–266.Google Scholar
7.Cohen, DR. Economic issues in infection control. J Hosp Infect 1984;5(suppl A):17–25.Google Scholar
8.Drummond, MF, Davies, LF. Evaluation of the costs and benefits of reducing hospital infection. J Hosp Infect 1991;18(suppl A):85–93.CrossRefGoogle ScholarPubMed
9.Graves, N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561–566.CrossRefGoogle ScholarPubMed
10.Graves, N, Halton, K, Lairson, D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007;28:178–184.CrossRefGoogle ScholarPubMed
11.Stone, PW, Braccia, D, Larson, E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005;33:501–509.Google Scholar
12.Graves, N, Weinhold, D. Complexity and the attribution of cost to hospital acquired infection. In: Roberts, JA, ed. Economics and Infectious Diseases. Oxford: Oxford University Press; 2006.Google Scholar
13.McGowan, JE Jr. Cost and benefit in control of nosocomial infection: methods for analysis. Rev Infect Dis 1981;3:790–797.Google Scholar
14.Katz, MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003;138:644–650.CrossRefGoogle ScholarPubMed
15.Haley, RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91(suppl 3B):32s–38s.Google Scholar
16.Freeman, J, McGowan, JE. Risk factors for nosocomial infection. J Infect Dis 1978;138:811–819.Google Scholar
17.Ramanathan, R. Introductory Econometrics. 4th ed. San Diego: Dryden Press, 1998.Google Scholar
18.Cooper, BS, Stone, SP, Kibbler, CC, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 2003;7:1–194.Google Scholar
19.Graves, N, Weinhold, D, Roberts, JAR. Correcting for bias when estimating the cost of hospital acquired infection: an analysis of lower respiratory tract infections in non-surgical patients. Health Econ 2005;14:755–761.Google Scholar
20.Clarke, SKR. Sepsis in surgical wounds, with particular reference to Staphlyococcus aureus. Br J Surg 1957;44:592–596.Google Scholar
21.Tambyah, PA, Knasinski, V, Maki, DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002;23:27–31.CrossRefGoogle ScholarPubMed
22.Aggarwal, R, Ghoshal, UC, Naik, SR. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol 2003;38:215–222.Google Scholar
23.Freeman, J, Rosner, BA, McGowan, JE. Adverse effects of nosocomial infection. J Infect Dis 1979;140:732–740.Google Scholar
24.Haley, RW, Schaberg, D, Crossley, K, Von Allmen, S, McGowan, J. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective inter-hospital comparison. Am J Med 1981;70:51–58.Google Scholar
25.Pena, C, Pujol, M, Pallares, R, et al. Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs. Medicina Clinica 1996;106:441–444.Google Scholar
26.Zhou, Q, Chu, D, Gao, X. A matched case-control study on direct economic costs of four kinds of nosocomial infections [in Chinese]. Zhon-ghua Liu Xing Bing Xue Za Zhi 2001;22:133–136.Google Scholar
27.Dietrich, ES, Demmler, M, Schulgen, G, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002;30:61–67.Google Scholar
28.Askarian, M, Gooran, NR. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control 2003;31:465–468.CrossRefGoogle ScholarPubMed
29.Kappstein, I, Daschner, F. Potential inroads to reducing hospital acquired staphylococcal infection and its cost. J Hosp Infect 1991;19(suppl B):31–34.Google Scholar
30.Kappstein, I, Schulgen, G, Beyer, U, Geiger, K, Schumacher, M, Daschner, FD. Prolongation of stay and extra cost due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504–508.Google Scholar
31.Rubinstein, E, Green, M, Modan, M, Amit, P, Bernstein, L, Rubenstein, A. The effect of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982;9(suppl A):93–100.Google Scholar
32.Givens, CD, Wenzel, RP. Catheter-associated urinary tract infections in surgical patients: a controlled study of the excess morbidity and costs. J Urol 1980;124:646–648.Google Scholar
33.Green, M, Rubenstein, E, Amit, P. Estimating the effects of nosocomial infections on the length of hospitalization. J Infect Dis 1982;145:667–672.Google Scholar
34.Coello, R, Glenister, H, Fereres, J, et al. The cost of infection in surgical patients: a case control study. J Hosp Infect 1993;25:239–250.Google Scholar
35.Medina, M, Martinez-Gallego, G, Sillero-Arenas, M, Delgado-Rodriguez, M. Risk factors and length of stay attributable to hospital infections of the urinary tract in general surgery patients [in Spanish]. Enferm Infecc Microbiol Clin 1997;15:310–314.Google Scholar
36.Moris de la Tassa, J, Fernandez Munoz, P, Antuna Egocheaga, A, Gutierrez del Rio, MC, Carton Sanchez, IA. Estimating the costs associated with nosocomial urinary tract infection: a case-control study [in Spanish]. Rev Clin Esp 2003;203:119–124.Google Scholar
37.Plowman, R, Graves, N, Griffin, MA, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198–209.Google Scholar
38.Warren, DK, Shukla, SJ, Olsen, MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312–1317.Google Scholar
39.Auslab [computer program]. Melbourne, Australia: PJA Computer Consultants; 1999.Google Scholar
40.Jones, FL, McMillan, J. Scoring occupational categories for social research: a review of current practice with Australian examples. Work Employ Soc 2001;15:539–563.CrossRefGoogle Scholar
41.National Centre for Classification in Health [NCCH]. International Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-W-AM). 3rd ed. Sydney, Australia: NCCH; 2002.Google Scholar
42.Aurich, E, Borgert, J, Butler, M, et al. Introduction to Australian surveillance definitions: surgical site infections and bloodstream infections. Aust Infect Control 2000;5:25–31.Google Scholar
43.Manning, WG, Mullahy, I. Estimating log models: to transform or not to transform? J Health Econ 2001;20:461–494.Google Scholar
44.Manning, W. RE: inskew question. Stata list server; December 9, 2002. Available at: http://www.stata.com/statalist/archive/2002-12/msg00193.html. Accessed August 2005.Google Scholar
45.McCullagh, P, Neider, IA. Generalized Linear Models. London: Chapman & Hall; 1989.Google Scholar
46.Manning, WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998;17:283–295.Google Scholar
47.Basu, A, Manning, WG, Mullahy, J. Comparing alternative models: log vs Cox proportional hazard? Health Econ 2004;13:749–765.CrossRefGoogle ScholarPubMed
48.White, H. A heteroscedasticity-consistent covariance matrix estimator and a direct test for heteroscedasticity. Econometrica 1980;48:817–838.CrossRefGoogle Scholar
49.Roberts, RR, Frutos, PW, Ciavarella, GC, et al. Distribution of fixed vs variable costs of hospital care. JAMA 1999;281:644–649.Google Scholar
50.Plowman, RP, Graves, N, Griffin, M, et al. The Socioeconomic Burden of Hospital Acquired Infection. London: Public Health Laboratory Service; 1999.Google Scholar
51.Dawson, D. Costs and Prices in the Internal Market: Markets vs the NHS Management Executive Guidelines. 1st ed. York: University of York; 1994.Google Scholar
52.Dawson, D, Goddard, M. Longer term agreements for health care services: what will they achieve?Discussion paper 157, Centre for Health Economics. York: University of York; 1998.Google Scholar
53.Harris, J. The internal organisation of hospitals: some economic implications. Bell J Econ 1977;8:467–482.Google Scholar